Mondou E - Search Results

1

A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.

Ejskjaer N, Wo JM, Esfandyari T, Mazen Jamal M, Dimcevski G, Tarnow L, Malik RA, Hellström PM, Mondou E, Quinn J, Rousseau F, McCallum RW. Ejskjaer N, et al. Among authors: mondou e. Neurogastroenterol Motil. 2013 Feb;25(2):e140-50. doi: 10.1111/nmo.12064. Epub 2012 Dec 23. Neurogastroenterol Motil. 2013. PMID: 23279217 Clinical Trial.

2

Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.

McCallum RW, Lembo A, Esfandyari T, Bhandari BR, Ejskjaer N, Cosentino C, Helton N, Mondou E, Quinn J, Rousseau F; TZP-102 Phase 2b Study Group. McCallum RW, et al. Among authors: mondou e. Neurogastroenterol Motil. 2013 Nov;25(11):e705-17. doi: 10.1111/nmo.12184. Epub 2013 Jul 15. Neurogastroenterol Motil. 2013. PMID: 23848826 Clinical Trial.

3

Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials.

Shaw M, Pediconi C, McVey D, Mondou E, Quinn J, Chamblin B, Rousseau F. Shaw M, et al. Among authors: mondou e. Dis Colon Rectum. 2013 Jul;56(7):888-97. doi: 10.1097/DCR.0b013e31829196d0. Dis Colon Rectum. 2013. PMID: 23739196 Clinical Trial.

4

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.

Ratziu V, Sheikh MY, Sanyal AJ, Lim JK, Conjeevaram H, Chalasani N, Abdelmalek M, Bakken A, Renou C, Palmer M, Levine RA, Bhandari BR, Cornpropst M, Liang W, King B, Mondou E, Rousseau FS, McHutchison J, Chojkier M. Ratziu V, et al. Among authors: mondou e. Hepatology. 2012 Feb;55(2):419-28. doi: 10.1002/hep.24747. Epub 2011 Dec 14. Hepatology. 2012. PMID: 22006541 Free PMC article. Clinical Trial.

5

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Marcellin P, et al. Among authors: mondou e. N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878. N Engl J Med. 2008. PMID: 19052126 Free article. Clinical Trial.

6

Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.

Lim SG, Krastev Z, Ng TM, Mechkov G, Kotzev IA, Chan S, Mondou E, Snow A, Sorbel J, Rousseau F. Lim SG, et al. Among authors: mondou e. Antimicrob Agents Chemother. 2006 May;50(5):1642-8. doi: 10.1128/AAC.50.5.1642-1648.2006. Antimicrob Agents Chemother. 2006. PMID: 16641430 Free PMC article. Clinical Trial.

7

Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.

Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E. Jonas MM, et al. Among authors: mondou e. Hepatology. 2008 Jun;47(6):1863-71. doi: 10.1002/hep.22250. Hepatology. 2008. PMID: 18433023 Clinical Trial.

8

Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection.

Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E. Jonas MM, et al. Among authors: mondou e. Pediatr Infect Dis J. 2012 Jun;31(6):578-82. doi: 10.1097/INF.0b013e318255ffe7. Pediatr Infect Dis J. 2012. PMID: 22466329 Clinical Trial.

9

Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study.

Gish RG, Trinh H, Leung N, Chan FK, Fried MW, Wright TL, Wang C, Anderson J, Mondou E, Snow A, Sorbel J, Rousseau F, Corey L. Gish RG, et al. Among authors: mondou e. J Hepatol. 2005 Jul;43(1):60-6. doi: 10.1016/j.jhep.2005.02.017. Epub 2005 Apr 11. J Hepatol. 2005. PMID: 15922478 Clinical Trial.

10

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.

Saag MS, Cahn P, Raffi F, Wolff M, Pearce D, Molina JM, Powderly W, Shaw AL, Mondou E, Hinkle J, Borroto-Esoda K, Quinn JB, Barry DW, Rousseau F; FTC-301A Study Team. Saag MS, et al. Among authors: mondou e. JAMA. 2004 Jul 14;292(2):180-9. doi: 10.1001/jama.292.2.180. JAMA. 2004. PMID: 15249567 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters